The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-methoxyphenyl)-3-(6-(trifluoromethoxy)benzo[d]thiazol-2-yl)urea ID: ALA2235013
PubChem CID: 76318808
Max Phase: Preclinical
Molecular Formula: C16H12F3N3O3S
Molecular Weight: 383.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(NC(=O)Nc2nc3ccc(OC(F)(F)F)cc3s2)cc1
Standard InChI: InChI=1S/C16H12F3N3O3S/c1-24-10-4-2-9(3-5-10)20-14(23)22-15-21-12-7-6-11(8-13(12)26-15)25-16(17,18)19/h2-8H,1H3,(H2,20,21,22,23)
Standard InChI Key: YQGWCCKERDHBMH-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
13.0984 -6.9007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0973 -7.7202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8053 -8.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8035 -6.4918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2930 -6.6394 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.5121 -6.8971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5147 -7.7220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3021 -7.9747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7811 -7.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5982 -7.2986 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0030 -6.5856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8202 -6.5812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5907 -5.8811 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.2326 -7.2857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8238 -7.9964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2356 -8.7004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0535 -8.6964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4582 -7.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0444 -7.2776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3918 -6.4920 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3918 -5.6748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4674 -9.4011 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0641 -10.1118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0996 -5.2663 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.6841 -5.2662 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.3858 -4.8536 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
6 7 1 0
5 6 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
1 20 1 0
20 21 1 0
17 22 1 0
22 23 1 0
21 24 1 0
21 25 1 0
21 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.35Molecular Weight (Monoisotopic): 383.0551AlogP: 4.85#Rotatable Bonds: 4Polar Surface Area: 72.48Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.29CX Basic pKa: ┄CX LogP: 5.22CX LogD: 4.88Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.68Np Likeness Score: -2.12
References 1. Caputo R, Calabro ML, Micale N, Schimmer AD, Ali M, Zappala M, Grasso S. (2012) Synthesis of benzothiazole derivatives and their biological evaluation as anticancer agents, 21 (9): [10.1007/s00044-011-9789-8 ] 2. Hroch L, Benek O, Guest P, Aitken L, Soukup O, Janockova J, Musil K, Dohnal V, Dolezal R, Kuca K, Smith TK, Gunn-Moore F, Musilek K.. (2016) Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment., 26 (15): [PMID:27287370 ] [10.1016/j.bmcl.2016.05.087 ]